Category: Pharma Industry

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Maryland, Missouri, West Virginia

September 6, 2024 340B Report Staff Views

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

Beacon Channel Management is holding multiple trainings on its 340B rebate platform.

The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

September 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.

German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Relents on Arkansas Contract Pharmacy Law; AbbVie Exempts MO, MS Covered Entities

September 4, 2024 Shannon Young, Associate Editor/Senior Writer & Bella Czajkowski, National Correspondent Views

Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.

Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.

Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions

September 3, 2024 Shannon Young, Associate Editor/Senior Writer Views

Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.

A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Two major hospital groups urged the government to take enforcement action against J&J's 340B rebate proposal.

Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding

August 29, 2024 Shannon Young, Associate Editor/Senior Writer Views

A new Berkeley Research Group issue brief looked at trends in 340B investments.

The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Judge Calls Astra Subpoenas ‘Overly Broad,’ Mo. Officials Push to Dismiss Lawsuit

August 29, 2024 Shannon Young, Associate Editor/Senior Writer & William Newton, Associate Editor/Senior Writer Views

Key orders and briefs were filed this week in state contract pharmacy litigation in Arkansas, Missouri and West Virginia.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live